67. Campen D., Horwitz D., Quismorio F. Jr, et al. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation.// Arthritis .Rheum. 1988. V.11. P. 1358-1364.
68. Ceriani R., Mazzoni M., Bortone F. et al. Application of the sequential organ failure assessment score to cardiac surgical patients // Chest. 2003. V.123. P. 1229-1239.
69. Cerra F., Siegel J. et al. Septic autocanibalism. //Ann. Surg. 1970. V. 192.
P. 570-577.
70. Cerra F.B. Multiple organ failure syndrome. 1989. P.11-34.
71. Cetinkaya Y., Akova M., Akalin H. et al. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. //Int. J. Antimicrob. Agents. 2001. V.18. P.1-7.
72. Chung K., Chang N., Park Y., Lee K. Effect of ultraviolet light on the expression of adhesion molecules and T lymphocyte adhesion to human dermal microvascular endothelial cells. //Yonsei Med. J. 2002. V.43. P.165-174.
73. Danforth J., Strieter R., Kunkel S. et al. Macrophage inflammatory protein-1 alpha expression in vivo and in vitro: the role of lipoteichoic acid. //Clin. Immunol. Immunopathol.1995 . V.74. P.77-83.
74. Deliconstantinos G., Villiotou V., Stavrides J. Nitric oxide and peroxynitrite released by ultraviolet B-irradiated human endothelial cells are possibly involved in skin erythema and inflammation. //Exp. Physiol. 1996. V. 81. P.1021-1033.
75. Dinarello C. The biological properties of interleikin-1. //Eur. Cytokin. Netw. 1994. V. 5. P. 517.
76. Dinarello C. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.// N. Engl. J. Med. 2000. V.10. P.732-734.
77. Djavaheri-Mergny M., Gras M., Mergny J., Dubertret L. UV-A-induced decrease in nuclear factor-kappaB activity in human keratinocytes. // Biochem. J.
1999. V.338 (Pt. 3). P.607-613.
78. Dries D. Interferon-gamma in trauma - related infection. // In: 8th Eur. Cong. Of Inten. Care Med. I. Main lectures. Ed. C. Roussos. Greece. 1995. P. 665-669.
79. Dupont B. Choice and use of antifungal drugs. //Rev. Prat. 2001.V.51. P.752-757.
80. Durack D., Lukes A., Bright D. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.// Am. J. Med. 1994. V. 96. P.200-209.
81. Edmunds L., Richard E. Surgery for acquired heart disease guidelines for reporting morbidity and mortality after cardiac valvular operations. //J. Thorac. And Cardiovasc. Surg. 1996. V. 112. P. 708 -712.
82. Eichler O., Sies H., Stahl W. Divergent optimum levels of lycopene, beta-carotene and lutein protecting against UVB irradiation in human fibroblastst. //Photochem. Photobiol. 2002. V.75. P.503-506.
83. Ellis M., Al-Abdely H., Sandridge A., et al. Fungal endocarditis: evidence in the world literature, 1965-1995. //Clin. Infect. Dis. 2001. P.50-62.
84. Engel J., Junger A., Zimmer M. et al. Correlation of a computerized SOFA score and derived measures with length of stay at an operative ICU //Anesthesiol. Intensivmed. Notfallmed. Schmerzther. 2003. V.38. P.397-402.
85. Evora P., Brasil J., Elias M. et al. Surgical extension of the vegetation as treatment of tricuspidal valve endocarditis // Cardiology. 1988. V.198. P. 208-212.
86. Ford I., Douglas C., Preston F., et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. //Br. J. Haematol. 1993. V.84. P. 95-100.
87. Forte W., Mario A., da Costa A. et al. Immunologic evaluation in infective endocarditis. //Arq. Bras. Cardiol. 2001. V.76. P.43-52.
88. Fraunberger P., Pilz G., Cremer P., et al. Association of serum tumor necrosis factor Levels with decrease of cholesterol during septic shock. //Shock.1998. N. 10. P. 359-363.
89. French L., Rook A. T - cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease. //Transfus. Apheresis Sci. 2002. V.26. P.191-196.
Уважаемый посетитель!
Чтобы распечатать файл, скачайте его (в формате Word).
Ссылка на скачивание - внизу страницы.